PacBio Supports SickKids to Investigate Use of HiFi Sequencing in Undiagnosed Genetic Conditions

MENLO PARK, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — PacBio, a leading provider of high-quality, highly accurate sequencing platforms, today announced it will be supporting The Hospital for Sick Children (SickKids) in Toronto, Canada in using HiFi whole genome sequencing (HiFi WGS) to potentially identify genetic variants that may be associated with medical and developmental... Read more

New Genetic Analyzer Brings Advanced Capabilities to Sanger Sequencing and Fragment Analysis

Thermo Fisher Scientific expands Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers CARLSBAD, Calif.–(BUSINESS WIRE)– Capillary electrophoresis (CE), which enables Sanger sequencing and fragment analysis,is an important tool for improving clinical research and advancing scientific discovery. To further enable customers’ cutting-edge research in areas such as gene editing and infectious disease,... Read more

Xylem Reports Fourth Quarter and Full-Year 2021 Earnings

Full-year organic growth, adjusted EBITDA margin expansion, adjusted earnings per share in line with November guidance Full-year revenue of $5.2 billion, up 7% on a reported basis, up 4% organically Full-year reported earnings per share of $2.35, up 68%; adjusted earnings per share of $2.49, up 21% Strong demand drives continuing commercial momentum in all... Read more

Bruker Announces Date and Time of Fourth Quarter 2021 Earnings Release and Webcast

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2021 financial results before market opening on Friday, February 11, 2022. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the... Read more

PerkinElmer Updates Fourth Quarter Outlook; To Hold Earnings Call on Tuesday, February 1, 2022

Fourth quarter 2021 revenue and earnings per share to exceed prior guidance Non-COVID organic growth in fourth quarter 2021 of approximately 10% Fourth quarter 2021 COVID product and services related revenue of approximately $320 million WALTHAM, Mass.–(BUSINESS WIRE)–Jan. 11, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today... Read more